top of page
At the Pediatrician
KTJF will use 100% of donations to provide
families battling pediatric cancer with  supportive
local care and advancement to a cure. 

 

IMPACT

CARE

Imagine a place where kids can discover, learn, play, and just be kids - in a hospital. Through a partnership between Kids Join the Fight and Children's Hospital New Orleans, that dream is becoming a reality.

 

Walker's Imaginarium at Children's Hospital New Orleans will be a therapeutic space for children, families, and even members of the community to gather, and create moments of joy. The 12,000 square foot center will be one of the largest and most comprehensive hospital-based child enrichment spaces in the country.

​

We will also provide meals to families in the hospitals across our region, and we are always on the lookout for additional ways we can ease the burden for children and their families affected by childhood cancer. Please reach out if you have ideas!

IMG_0154.JPG
CARE
Brain Scans

CURE

In May of 2023, KJTF  proudly awarded $275,000 in new grants to researchers across the country working to cure pediatric brain cancer in 2023.

​

Kids Join the Fight grants are awarded based on a competitive dual peer-review process conducted by both the Kids Join the Fight Medical Advisory Board and the Rally Foundation’s Medical Advisory Board, which are both comprised of leading childhood cancer experts. The grants fund all levels of research, from science at the bench to translational, and they include fellows, young investigators and independent investigators. Kids Join the Fight focuses funding on pediatric brain cancers with a specific emphasis on treatments that could both cure children and reduce the debilitating secondary effects of common cancer treatments on their growing bodies.

​

This year we are proud to support the following researchers and believe via these or our future partners your support will contribute to the curing of pediatric brain cancer:
 

  • Baylor College of Medicine: Dr. Jamie Anastas for Targeting the SAGA Chromatin Regulatory Complex in DMG

  • University of Alabama at Birmingham: Dr. Rintaro Hashizume for Targeted Inhibition of EZH2 and BET BRD4 for the Treatment of AT/RT

  • The Hospital for Sick Children: Dr. Cynthia Hawkins for Integrated Characterization of Disseminated Pediatric Low-Grade Glioma

  • SonALAsense, Inc.: Dr. Stuart Marcus for A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000

  • The Hospital for Sick Children: Dr. Vijay Ramaswamy for New Therapies for Very High-Risk TP53 Mutant Medulloblastoma

  • National Brain Tumor Society: Dr. Kirk Tanner for The DNA Damage Response (DDR) Consortium

  • Dana-Farber Cancer Institute: Dr. Jessica Tsai for Dissecting FOXR2-mediated Oncogenesis in Diffuse Midline Gliomas

  • University of Michigan: Dr. John Prensner for Oncogenic uORFs as the Next Frontier for Medulloblastoma Target Genes 

​

In addition, we also partnered with the Rally Foundation to fund Outside the Box Grants:

  • Baylor College of Medicine: Dr. Tamra Werbowetski-Ogilvie for therapeutic targeting of alternatively spliced genes in medulloblastoma

  • Johns Hopkins School of Medicine: Dr. Challice Bonifant for Anti-B7H3 CAR-NK cells for atypical teratoid rhabdoid tumors

CURE
bottom of page